Survey of Barriers and Facilitators to Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment Act of 2000 Waiver.

ABSTRACT:

Importance

As opioid-related deaths continue to climb, methods to reduce barriers to prescribing buprenorphine for individuals with opioid use disorder (OUD) are needed. Recent conversations by state and federal authorities targeting low-threshold buprenorphine aim to reduce some barriers to prescribing buprenorphine; however, what remains unclear is whether removal of the requirement to obtain a waiver for prescribing buprenorphine through the Drug Addiction Treatment Act of 2000 (an X-waiver) will be enough to increase access to buprenorphine.

Objective

To assess barriers and facilitators of obtaining an X-waiver and prescribing buprenorphine.

Design, setting, and participants

This mixed-method survey study was conducted between September and December 2020; 607 offi

SUBMITTER: Lanham HJ 

PROVIDER: S-EPMC9099423 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature